Chiral Masterclass: Practical Playbook for Challenging Separations

Preparative Chromatographer, GlaxoSmithKline

With more than 36 years of experience, Mark is a veteran Preparative Chromatographer focused on turning analytical methods into robust, scalable purification processes. He brings deep experience in chiral and achiral separations, method optimization, and GMP-compliant workflows across discovery and development. Mark’s work has supported the successful discovery and development of several FDA-approved drugs now on the market, including Hycamtin IV and Oral Hycamtin (topotecan), BLENREP, Gepotidacin (Blujepa), and Duvroq (daprodustat).

Principal Scientist, Bristol-Myers Squibb

Dr. Ines Santos is a Principal Scientist in the Precision Medicine, Bioanalytical, and Translational Sciences group at BMS. She is responsible for the development of LC-MS/MS methods to characterize pharmacokinetic/toxicokinetic properties of development programs. In addition, she provides oversight of outsourced GLP bioanalytical validations and sample analysis for pharmacokinetic studies. Ines received her PhD in Biotechnology (Analytical Chemistry) from the Portuguese Catholic University.

Sr Product Manager, Daicel Chiral Technologies

Dr. Weston Umstead holds a PhD in Chemistry from the University of Denver and has been with Daicel Chiral Technologies since 2016. As Sr. Product Manager, he oversees the company’s analytical and custom separation services – helping scientists around the world develop faster, more reliable methods.

Associate Director, Incyte

Ron Magboo has more than 15 years of success in the pharmaceutical industry. A technology-driven chromatographer and SFC specialist. He focuses on method development and scale-up purification of chiral/achiral small molecules, metabolite/impurity isolation.  Ron also has extensive experience in evaluation and implementation of new technologies and automation especially for QC and solubility/stability assays.

Business Development Specialist, Shimadzu Scientific Instruments

Steve brings over 34 years of experience in the pharmaceutical industry. Trained as a medicinal chemist, he spent many years at DuPont, Bayer, and Bristol Myers Squibb, contributing to early-phase drug discovery across multiple therapeutic areas. He later transitioned from the laboratory into roles in scientific support, sales, and business development with leading instrumentation companies. Since joining Shimadzu in 2020 as a Business Development Specialist, Steve has partnered with pharma and biopharma customers, leveraging his broad experience to help optimize

Daicel Chiral Technologies and Shimadzu, combine decades of experience in separation science and analytical instrumentation to deliver a hands-on learning experience focused on real-world chiral challenges.

Bringing column chemistry and instrumentation together.